Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX)

Q: What does CUSIP G7709Q104 represent in this 13F holders report?

CUSIP G7709Q104 is the security identifier for RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share in Q2 2022?

281 institutional investors reported RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share for Q2 2022. Use the holders table for investor-level position and value details.

CUSIP: G7709Q104

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Class A Ordinary Shares, par value $0.0001 per share
Shares outstanding: 424,966,351
Total 13F shares: 291,545,338
Share change: +21,373,664
Total reported value: $12,256,604,812
Put/Call ratio: 6.1%
Price per share: $42.04
Number of holders: 281
Value change: +$918,924,477
Number of buys: 155
Number of sells: 125

Quarterly Holders Quick Answers

What is CUSIP G7709Q104?
CUSIP G7709Q104 identifies RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP G7709Q104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RPRX - Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
MORGAN STANLEY	13F	Company	13%	53,541,788	$2,085,987,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	7.5%	31,860,621	$1,241,289,000	—	31 Mar 2022	13F
FMR LLC	13F	Company	6.6%	28,205,155	$1,098,872,000	—	31 Mar 2022	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	5.8%	24,842,715	$967,872,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	4.1%	17,483,188	$681,145,000	—	31 Mar 2022	13F
VIKING GLOBAL INVESTORS LP	13F	Company	2.5%	10,764,472	$419,384,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	1.8%	7,762,572	$302,430,000	—	31 Mar 2022	13F
SIGULER GUFF ADVISERS, LLC	13F	Company	1.6%	6,761,970	$263,446,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	1.3%	5,559,388	$216,592,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.2%	5,009,649	$194,913,000	—	31 Mar 2022	13F
Capital International Investors	13F	Company	1.2%	4,993,590	$194,550,000	—	31 Mar 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.73%	3,099,830	$120,769,000	—	31 Mar 2022	13F
NORGES BANK	13F	Company	0.72%	3,071,396	$119,661,588	—	31 Mar 2022	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.65%	2,782,826	$108,417,000	—	31 Mar 2022	13F
Vantage Consulting Group Inc	13F	Company	0.64%	2,727,854	$106,277,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.57%	2,408,684	$93,842,000	—	31 Mar 2022	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.53%	2,261,199	$88,096,000	—	31 Mar 2022	13F
Aberdeen Group plc	13F	Company	0.53%	2,239,130	$87,450,000	—	31 Mar 2022	13F
Legal & General Group Plc	13F	Company	0.5%	2,124,840	$82,784,000	—	31 Mar 2022	13F
Marathon Asset Management Ltd	13F	Company	0.49%	2,076,728	$80,908,000	—	31 Mar 2022	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	13F	Company	0.48%	2,025,610	$78,918,000	—	31 Mar 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.46%	1,960,528	$76,382,000	—	31 Mar 2022	13F
Point72 Asset Management, L.P.	13F	Company	0.45%	1,892,900	$73,747,000	—	31 Mar 2022	13F
William E. Ford	3/4/5	Director	— class O/S missing	2,586,134	$71,241,786	—	30 Jun 2021	3/4/5
TimesSquare Capital Management, LLC	13F	Company	0.39%	1,650,900	$64,319,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.37%	1,583,133	$61,679,000	—	31 Mar 2022	13F
GENERAL ATLANTIC, L.P.	13F	Individual	0.35%	1,500,000	$58,440,000	—	31 Mar 2022	13F
BERKSHIRE HATHAWAY INC	13F	Company	0.35%	1,496,372	$58,299,000	—	31 Mar 2022	13F
Swiss National Bank	13F	Company	0.35%	1,488,310	$57,985,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.33%	1,387,630	$54,062,000	—	31 Mar 2022	13F
HOMESTEAD ADVISERS CORP	13F	Company	0.32%	1,346,540	$52,461,000	—	31 Mar 2022	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.3%	1,292,117	$50,331,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.28%	1,203,632	$46,892,000	—	31 Mar 2022	13F
Sloan Kettering Cancer Center Memorial	13F	Individual	0.27%	1,128,255	$43,957,000	—	31 Mar 2022	13F
BAILLIE GIFFORD & CO	13F	Company	0.27%	1,127,031	$43,909,000	—	31 Mar 2022	13F
EATON VANCE MANAGEMENT	13F	Company	0.26%	1,115,048	$43,443,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.25%	1,074,421	$41,860,000	—	31 Mar 2022	13F
ROBERT WOOD JOHNSON FOUNDATION	13F	Company	0.23%	970,151	$37,797,000	—	31 Mar 2022	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.22%	938,381	$36,559,323	—	31 Mar 2022	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	0.22%	920,681	$35,870,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.22%	917,431	$35,743,000	—	31 Mar 2022	13F
Indie Asset Partners, LLC	13F	Company	0.18%	756,874	$29,488,000	—	31 Mar 2022	13F
Overbrook Management Corp	13F	Company	0.17%	723,250	$28,178,000	—	31 Mar 2022	13F
Invesco Ltd.	13F	Company	0.16%	683,367	$26,623,000	—	31 Mar 2022	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.15%	639,350	$24,909,000	—	31 Mar 2022	13F
Brown University	13F	Company	0.15%	621,759	$24,224,000	—	31 Mar 2022	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	0.14%	592,477	$23,083,000	—	31 Mar 2022	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.13%	566,475	$22,070,000	—	31 Mar 2022	13F
Graypoint LLC	13F	Company	0.13%	565,674	$22,039,000	—	31 Mar 2022	13F
Swedbank AB	13F	Company	0.12%	493,517	$19,227,422	—	31 Mar 2022	13F

Institutional Holders of Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX) as of Q2 2022

As of 30 Jun 2022, Royalty Pharma plc - Class A Ordinary Shares, par value $0.0001 per share (RPRX) was held by 281 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 291,545,338 shares. The largest 10 holders included MORGAN STANLEY, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., BAILLIE GIFFORD & CO, ADAGE CAPITAL PARTNERS GP, L.L.C., VIKING GLOBAL INVESTORS LP, JPMORGAN CHASE & CO, STATE STREET CORP, and SIGULER GUFF ADVISERS, LLC. This page lists 281 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

272

Q2 2022 holders

281

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.